Cite
ALK inhibitor-induced bradycardia: A systematic-review and meta-analysis
MLA
Shijie Zhou, et al. “ALK Inhibitor-Induced Bradycardia: A Systematic-Review and Meta-Analysis.” Lung Cancer, vol. 161, Nov. 2021, pp. 9–17. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....7ef1a6b19c064902dce8acc2fdbe17d2&authtype=sso&custid=ns315887.
APA
Shijie Zhou, Peter M. Ellis, Carly Barron, Filipe Cirne, Adam El-Kadi, Coralea Kappel, Stephanie Sanger, & Darryl P. Leong. (2021). ALK inhibitor-induced bradycardia: A systematic-review and meta-analysis. Lung Cancer, 161, 9–17.
Chicago
Shijie Zhou, Peter M. Ellis, Carly Barron, Filipe Cirne, Adam El-Kadi, Coralea Kappel, Stephanie Sanger, and Darryl P. Leong. 2021. “ALK Inhibitor-Induced Bradycardia: A Systematic-Review and Meta-Analysis.” Lung Cancer 161 (November): 9–17. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....7ef1a6b19c064902dce8acc2fdbe17d2&authtype=sso&custid=ns315887.